UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention
UNC Lineberger Comprehensive Cancer Center has joined 68 of the nation's top cancer centers in urging increased vaccination for the human papillomavirus, or HPV. Recognizing insufficient vaccination rates present a public health threat, this nationwide network of experts is calling upon physicians, parents and young adults to take advantage of this rare opportunity to prevent many types of cancer.
Based on a survey of widowed fathers who had lost a spouse to cancer, UNC Lineberger researchers reported in the journal BMJ Palliative Care that additional research and improved end-of-life care are needed to specifically help dying parents as well as their families.
A preclinical study led by a UNC Lineberger researcher found that a nanoparticule form of a drug used to prevent bone loss was effective against small-cell lung and prostate cancer cells. The results were published in the journal Biomaterials.
UNC Lineberger was awarded a grant with the Medical University of South Carolina Hollings Cancer Center to support a collaborative effort to address disparities in cancer incidence and death across North and South Carolina and Tennessee. In addition, the cancer center has received a grant to support the work of a community health educator to enhance outreach and education, and to disseminate culturally-appropriate, evidence-based cancer information in North Carolina.